Amphastar Pharmaceuticals, Inc. financial data

Symbol
AMPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
11570 Sixth Street, Rancho Cucamonga, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 236 % -15.7%
Quick Ratio 51.8 % -30.8%
Return On Equity 25.4 % +35.4%
Return On Assets 10.9 % -3.46%
Operating Margin 32.3 % +32.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.7M shares -0.37%
Common Stock, Shares, Outstanding 49M shares +0.29%
Entity Public Float 1.49B USD +68%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.9M shares +1.04%
Weighted Average Number of Shares Outstanding, Diluted 52M shares -1.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 713M USD +31.8%
Cost of Revenue 323M USD +22.1%
Research and Development Expense 71.8M USD -0.87%
Selling and Marketing Expense 33.4M USD +38.7%
General and Administrative Expense 54.7M USD +13.1%
Operating Income (Loss) 230M USD +75%
Nonoperating Income (Expense) -26.8M USD -2217%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 203M USD +56%
Income Tax Expense (Benefit) 35.1M USD +30.1%
Net Income (Loss) Attributable to Parent 167M USD +63.3%
Earnings Per Share, Basic 3.44 USD/shares +63%
Earnings Per Share, Diluted 3.15 USD/shares +63.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 190M USD +27.6%
Accounts Receivable, after Allowance for Credit Loss, Current 131M USD +25.5%
Inventory, Net 122M USD +17%
Assets, Current 483M USD +25.5%
Deferred Income Tax Assets, Net 53.3M USD +30.3%
Property, Plant and Equipment, Net 288M USD +3.4%
Operating Lease, Right-of-Use Asset 32.1M USD +21.9%
Goodwill 3.13M USD -1.14%
Other Assets, Noncurrent 24.3M USD +19.7%
Assets 1.49B USD +8.22%
Accounts Payable, Current 31.8M USD +68.7%
Employee-related Liabilities, Current 26.5M USD +6.25%
Accrued Liabilities, Current 99.4M USD -50%
Liabilities, Current 137M USD -45.5%
Long-term Debt and Lease Obligation 587M USD +20.2%
Accrued Income Taxes, Noncurrent 6.07M USD -16%
Deferred Income Tax Liabilities, Net 201K USD -16.9%
Operating Lease, Liability, Noncurrent 29.5M USD +20.8%
Other Liabilities, Noncurrent 18.8M USD +6.64%
Liabilities 778M USD -1.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.83M USD -6.03%
Retained Earnings (Accumulated Deficit) 490M USD +51.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 713M USD +21.1%
Liabilities and Equity 1.49B USD +8.22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 55.3M USD +36.9%
Net Cash Provided by (Used in) Financing Activities -13.6M USD -0.23%
Net Cash Provided by (Used in) Investing Activities 15.2M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 60.5M shares +2.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 56.9M USD +177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 190M USD +25.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.63M USD +593%
Deferred Tax Assets, Valuation Allowance 20.5M USD +4.04%
Deferred Tax Assets, Gross 112M USD +20.6%
Operating Lease, Liability 33.6M USD +26%
Depreciation 6.82M USD +9.02%
Payments to Acquire Property, Plant, and Equipment 8.79M USD -7.22%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 166M USD +62.2%
Lessee, Operating Lease, Liability, to be Paid 41.5M USD +28%
Property, Plant and Equipment, Gross 546M USD +6.91%
Operating Lease, Liability, Current 4M USD +27.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.54M USD +47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.61M USD +37.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.88M USD +37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.59M USD +53.7%
Deferred Tax Assets, Operating Loss Carryforwards 20.2M USD +0.68%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 12.5M USD -3.12%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.36M USD +51.6%
Additional Paid in Capital 488M USD +3.49%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.17M USD +2459%
Depreciation, Depletion and Amortization 38.6M USD +190%
Share-based Payment Arrangement, Expense 22.4M USD +14.4%
Interest Expense 35.4M USD +1772%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%